In addition, the percentages of effector T cells (GZMB+CD8+) in CD8+ T cells surrounding the tumor nests were significantly enriched (P < 0.01, Figure 8M), indicating that TDO2 inhibition enhanced the effector function of CD8+ T cells to exert the antitumor effect. Here, CD8A is linked to neoplasm.